News
Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an additional $50.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback